“Smoldering multiple myeloma” (SMM) is a blood and bone marrow disorder which can lead to multiple myeloma, a deadly cancer.
A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition ...
Early interventions with daratumumab reduced progression and prolonged overall survival rate in patients with high-risk ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Treating high-risk smoldering multiple myeloma with single-agent daratumumab (Darzalex) delayed progression to active ...
Hosted on MSN27d
Treatment of Smoldering Myeloma Cuts Progression Rate in HalfSAN DIEGO -- The risk of progression from smoldering multiple myeloma to symptomatic disease decreased by 50% in patients treated with the anti-CD38 monoclonal antibody daratumumab (Darzalex ...
Myeloma specialist Dr. Urvi Shah is researching the role that whole-food and plant-based diets may play in slowing the progression of certain conditions into multiple myeloma. Many people who are ...
Darzalex Faspro improved PFS and OS in high-risk smoldering multiple myeloma, reducing progression or death risk by 51% and death risk by 48%. The AQUILA study showed a superior overall response rate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback